These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1786479)

  • 21. Shifting from an illegal-drug policy to a psychoactive substance policy.
    van der Linde F
    Soz Praventivmed; 2006; 51(3):128-9. PubMed ID: 17191533
    [No Abstract]   [Full Text] [Related]  

  • 22. Misuse of psychotropic substances: outline and recommendations of a conference held in London in March 1980.
    Ghodse AH; Khan I
    Bull Narc; 1982; 34(3-4):83-90. PubMed ID: 6926514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 10-year review of drug seizures in Singapore.
    Lee TK; Chow ST; Ng TL
    Med Sci Law; 1998 Oct; 38(4):311-6. PubMed ID: 9808942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statement on national drug policy. College on problems of drug dependence.
    Drug Alcohol Depend; 1997 Jul; 47(1):63-71. PubMed ID: 9279499
    [No Abstract]   [Full Text] [Related]  

  • 25. Are drug policies based on 'fake' statistics?
    Sutton M; Maynard A
    Addiction; 1993 Apr; 88(4):455-8. PubMed ID: 8485423
    [No Abstract]   [Full Text] [Related]  

  • 26. The World Health Organization's Expert Committee on drug dependence: comments on the 28th report (1994).
    Negrete JC
    Addiction; 1995 Nov; 90(11):1437-9. PubMed ID: 8528021
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is drug prohibition an effective tool? An analysis from the forensic viewpoint].
    Stratenwerth G
    Psychiatr Prax; 1994 Jan; 21(1):3-6. PubMed ID: 8146243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drugs--a continuous challenge for Europe. But clear retreat by EU from purely reactive to prospective management].
    Kinderkrankenschwester; 2002 Jan; 21(1):21-3. PubMed ID: 14606240
    [No Abstract]   [Full Text] [Related]  

  • 29. [Legal and illegal drugs--status, selected problems, trends].
    Katzung W
    Z Arztl Fortbild (Jena); 1992 Jul; 86(14):689-99. PubMed ID: 1529620
    [No Abstract]   [Full Text] [Related]  

  • 30. Biological evaluation of compounds for their physical dependence potential and abuse liability. XIII. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc.
    Jacobson AE
    NIDA Res Monogr; 1989; 95():556-77. PubMed ID: 2641053
    [No Abstract]   [Full Text] [Related]  

  • 31. The regulatory challenges in engineering a safer tipple.
    Hall W
    J Psychopharmacol; 2006 May; 20(3):321-2, discussion 331. PubMed ID: 16574704
    [No Abstract]   [Full Text] [Related]  

  • 32. For alcohol alternatives, the science is not the hardest part.
    Room R
    J Psychopharmacol; 2006 May; 20(3):323-4, discussion 331. PubMed ID: 16574705
    [No Abstract]   [Full Text] [Related]  

  • 33. Principles of assessment of abuse liability: US legal framework and regulatory environment.
    Rocha BA
    Behav Pharmacol; 2013 Sep; 24(5-6):403-9. PubMed ID: 23820327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conference on abuse liability assessment of CNS drugs.
    Schuster CR; Henningfield J
    Drug Alcohol Depend; 2003 Jun; 70(3 Suppl):S1-4. PubMed ID: 12759193
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulatory approaches to new psychoactive substances (NPS) in the European Union.
    Hughes B; Griffiths P
    Addiction; 2014 Oct; 109(10):1591-3. PubMed ID: 25163707
    [No Abstract]   [Full Text] [Related]  

  • 36. "Alcohol alternatives: a goal for psychopharmacology?" by David J. Nutt.
    Cox WM
    J Psychopharmacol; 2006 May; 20(3):327-8, discussion 331. PubMed ID: 16574707
    [No Abstract]   [Full Text] [Related]  

  • 37. Tineptine: Why has not been classified as a narcotic in Spain?
    Calabozo B; Molina V; Uribe F
    Rev Psiquiatr Salud Ment; 2016; 9(3):176-7. PubMed ID: 26927533
    [No Abstract]   [Full Text] [Related]  

  • 38. [Abuse-related adverse drug reactions and abuse deterrent formulations].
    Papaseit E; Pérez-Mañá C; Torrens M; Farré M
    Med Clin (Barc); 2013 Nov; 141(10):454-8. PubMed ID: 24144061
    [No Abstract]   [Full Text] [Related]  

  • 39. Substance abuse and control in the United States: ethical and legal issues.
    Newcomb MD
    Soc Sci Med; 1992 Aug; 35(4):471-9. PubMed ID: 1519100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulating mandatory medical prescription.
    Mitchell CN
    Am J Law Med; 1986; 12(2):207-39. PubMed ID: 3327377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.